vs

Side-by-side financial comparison of BIOHARVEST SCIENCES INC. (BHST) and Virgin Galactic Holdings, Inc (SPCE). Click either name above to swap in a different company.

BIOHARVEST SCIENCES INC. is the larger business by last-quarter revenue ($8.4M vs $4.2M, roughly 2.0× Virgin Galactic Holdings, Inc).

BioHarvest Sciences Inc. is a biotechnology firm that develops and produces sustainable, high-purity plant-derived bioactive ingredients. It serves the nutraceutical, cosmetics, and pharmaceutical sectors, leveraging proprietary cell cultivation technology to create efficacious natural products without large-scale agricultural farming.

Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.

BHST vs SPCE — Head-to-Head

Bigger by revenue
BHST
BHST
2.0× larger
BHST
$8.4M
$4.2M
SPCE

Income Statement — Q3 FY2025 vs Q2 FY2024

Metric
BHST
BHST
SPCE
SPCE
Revenue
$8.4M
$4.2M
Net Profit
$-93.8M
Gross Margin
60.3%
-546.6%
Operating Margin
-2412.1%
Net Margin
-2222.2%
Revenue YoY
125.5%
Net Profit YoY
30.2%
EPS (diluted)
$-4.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BHST
BHST
SPCE
SPCE
Q3 25
$8.4M
Q2 25
$8.1M
Q1 25
$7.7M
Q3 24
$6.5M
Q2 24
$6.0M
$4.2M
Q1 24
$2.0M
Q4 23
$2.8M
Q3 23
$1.7M
Net Profit
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$-93.8M
Q1 24
$-102.0M
Q4 23
$-104.0M
Q3 23
$-104.6M
Gross Margin
BHST
BHST
SPCE
SPCE
Q3 25
60.3%
Q2 25
60.0%
Q1 25
58.2%
Q3 24
Q2 24
-546.6%
Q1 24
-1038.1%
Q4 23
-766.4%
Q3 23
-1384.3%
Operating Margin
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
-2412.1%
Q1 24
-5599.9%
Q4 23
-4067.8%
Q3 23
-6613.0%
Net Margin
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
-2222.2%
Q1 24
-5139.1%
Q4 23
-3701.8%
Q3 23
-6053.5%
EPS (diluted)
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$-4.36
Q1 24
$-5.10
Q4 23
$-14.49
Q3 23
$-5.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BHST
BHST
SPCE
SPCE
Cash + ST InvestmentsLiquidity on hand
$775.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$394.8M
Total Assets
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$775.7M
Q1 24
$765.2M
Q4 23
$874.0M
Q3 23
$997.1M
Stockholders' Equity
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$394.8M
Q1 24
$417.6M
Q4 23
$505.5M
Q3 23
$599.4M
Total Assets
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$1.1B
Q1 24
$1.1B
Q4 23
$1.2B
Q3 23
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BHST
BHST
SPCE
SPCE
Operating Cash FlowLast quarter
$-79.1M
Free Cash FlowOCF − Capex
$-113.5M
FCF MarginFCF / Revenue
-2690.7%
Capex IntensityCapex / Revenue
815.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-458.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$-79.1M
Q1 24
$-113.2M
Q4 23
$-95.3M
Q3 23
$-91.5M
Free Cash Flow
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
$-113.5M
Q1 24
$-126.3M
Q4 23
$-113.7M
Q3 23
$-104.8M
FCF Margin
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
-2690.7%
Q1 24
-6362.8%
Q4 23
-4046.9%
Q3 23
-6066.1%
Capex Intensity
BHST
BHST
SPCE
SPCE
Q3 25
Q2 25
Q1 25
Q3 24
Q2 24
815.5%
Q1 24
658.5%
Q4 23
653.9%
Q3 23
771.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons